Home LiteratureArticle Details
PMID: 10834949 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Quantitative molecular analysis of virus expression and replication.

Journal of clinical microbiology ·Vol. 38 ·No. 6 ·2000-06-00 ·Pages 2030-6

Clementi M

Abstract

暂无摘要

MeSH Terms
Antiviral Agents/therapeutic use DNA, Viral/isolation & purification Humans Molecular Biology/methods RNA, Viral/isolation & purification Virology/methods Virus Diseases/drug therapy Virus Replication Viruses/genetics,pathogenicity
Chemicals
Antiviral Agents DNA, Viral RNA, Viral
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Clementi M
Department of Biomedical Sciences, University of Trieste, Trieste, Italy. clementi@popcsi.unian.it
References (101)
101 references, click to expand
  1. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.
    N Engl J Med. 1995 Jan 26;332(4):209-16 PMID: 7808486
  2. Viral dynamics in human immunodeficiency virus type 1 infection.
    Nature. 1995 Jan 12;373(6510):117-22 PMID: 7529365
  3. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
    Nature. 1995 Jan 12;373(6510):123-6 PMID: 7816094
  4. Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals.
    J Virol. 1995 Apr;69(4):2092-2100 PMID: 7884855
  5. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.
    Ann Intern Med. 1995 Apr 15;122(8):573-9 PMID: 7887550
  6. Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds.
    J Clin Microbiol. 1995 Jan;33(1):16-23 PMID: 7699034
  7. Viral dynamics in hepatitis B virus infection.
    Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4398-402 PMID: 8633078
  8. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.
    Science. 1996 May 24;272(5265):1167-70 PMID: 8638160
  9. Quantitation of cytomegalovirus DNA and characterization of viral gene expression in bronchoalveolar cells of infected patients with and without pneumonitis.
    J Infect Dis. 1996 Jun;173(6):1304-12 PMID: 8648201
  10. Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.
    Clin Microbiol Rev. 1996 Apr;9(2):135-47 PMID: 8964032
  11. Quantitative dynamics of HIV type 1 expression.
    AIDS Res Hum Retroviruses. 1996 Jan 20;12(2):117-126 PMID: 8834461
  12. Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo.
    J Virol. 1996 Nov;70(11):7603-13 PMID: 8892880
  13. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology.
    Hepatology. 1996 Nov;24(5):1003-9 PMID: 8903367
  14. Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis.
    J Hepatol. 1996 Oct;25(4):433-8 PMID: 8912141
  15. Detection of HIV-1 RNA by nucleic acid sequence-based amplification combined with fluorescence correlation spectroscopy.
    Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):12811-6 PMID: 8917501
  16. Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system.
    J Clin Microbiol. 1996 Dec;34(12):2933-6 PMID: 8940425
  17. Hepatitis C virus infection and mixed cryoglobulinaemia: assessment of HCV RNA copy numbers in supernatant, cryoprecipitate and non-liver cells.
    J Viral Hepat. 1996 Nov;3(6):285-92 PMID: 8947879
  18. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.
    Virology. 1996 Dec 15;226(2):205-16 PMID: 8955040
  19. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study.
    AIDS. 1996 Dec;10(14):F51-6 PMID: 8970677
  20. Successful quantification of cytomegalovirus DNA by competitive PCR and detection with capillary electrophoresis.
    Mol Cell Probes. 1997 Feb;11(1):11-23 PMID: 9076710
  21. Quantitative liver parameters of HCV infection: relation to HCV genotypes, viremia and response to interferon treatment.
    J Hepatol. 1997 Apr;26(4):779-86 PMID: 9126789
  22. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    J Med Virol. 1997 May;52(1):105-12 PMID: 9131466
  23. Decay characteristics of HIV-1-infected compartments during combination therapy.
    Nature. 1997 May 8;387(6629):188-91 PMID: 9144290
  24. Quantitation of parvovirus B19 DNA sequences by competitive PCR: differential hybridization of the amplicons and immunoenzymatic detection on microplate.
    Mol Cell Probes. 1997 Apr;11(2):127-33 PMID: 9160327
  25. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease.
    AIDS. 1997 Jun;11(7):889-93 PMID: 9189214
  26. Virus dynamics and drug therapy.
    Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6971-6 PMID: 9192676
  27. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa.
    Hepatology. 1997 Jul;26(1):226-31 PMID: 9214474
  28. Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange.
    J Infect Dis. 1997 Sep;176(3):801-4 PMID: 9291338
  29. Mutations in the 5' end of the herpes simplex virus type 2 latency-associated transcript (LAT) promoter affect LAT expression in vivo but not the rate of spontaneous reactivation of genital herpes.
    J Virol. 1997 Oct;71(10):7903-10 PMID: 9311880
  30. Quantitative analysis of hepatitis C virus activity in vivo in different groups of untreated patients.
    Arch Virol. 1997;142(3):465-72 PMID: 9349293
  31. Detection of hepatitis C virus RNA in CD19 peripheral blood mononuclear cells of chronically infected patients.
    J Infect Dis. 1997 Nov;176(5):1209-14 PMID: 9359720
  32. Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.
    J Clin Invest. 1998 Jan 15;101(2):497-502 PMID: 9435323
  33. A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs.
    Antimicrob Agents Chemother. 1998 Feb;42(2):269-76 PMID: 9527771
  34. The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation.
    J Virol. 1998 Jul;72(7):5343-50 PMID: 9620987
  35. Use of multiple competitors for quantification of human immunodeficiency virus type 1 RNA in plasma.
    J Clin Microbiol. 1998 Jul;36(7):1864-70 PMID: 9650926
  36. Quantitation of cytomegalovirus: methodologic aspects and clinical applications.
    Clin Microbiol Rev. 1998 Jul;11(3):533-54 PMID: 9665982
  37. Recent advances in antiretroviral therapy and HIV infection monitoring.
    Intervirology. 1997;40(5-6):304-21 PMID: 9675636
  38. Viral load in samples from hepatitis C virus (HCV)-infected patients with various clinical conditions.
    Res Virol. 1995 Jul-Aug;146(4):279-84 PMID: 8539490
  39. Presence of hepatitis C virus (HCV) genomic RNA and viral replicative intermediates in bone marrow and peripheral blood mononuclear cells from HCV-infected patients.
    Clin Diagn Lab Immunol. 1994 Mar;1(2):160-3 PMID: 7496938
  40. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.
    Science. 1996 Mar 15;271(5255):1582-6 PMID: 8599114
  41. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission.
    J Virol. 1996 May;70(5):3098-107 PMID: 8627789
  42. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.
    J Infect Dis. 1998 Aug;178(2):413-22 PMID: 9697721
  43. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
    New Microbiol. 1998 Jul;21(3):293-308 PMID: 9699213
  44. Quantification of viral load: clinical relevance for human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection.
    Intervirology. 1998;41(1):24-34 PMID: 9705562
  45. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.
    Science. 1998 Oct 2;282(5386):103-7 PMID: 9756471
  46. Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay.
    J Virol Methods. 1998 Oct;74(2):155-65 PMID: 9779615
  47. Design of HIV viral dynamics studies.
    Stat Med. 1998 Nov 15;17(21):2421-34 PMID: 9819837
  48. Estimation of HIV dynamic parameters.
    Stat Med. 1998 Nov 15;17(21):2463-85 PMID: 9819839
  49. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA.
    J Clin Microbiol. 1999 Feb;37(2):327-32 PMID: 9889212
  50. Dynamics of macrophage and T cell infection by HIV.
    J Theor Biol. 1999 Jan 7;196(1):101-13 PMID: 9892559
  51. Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture.
    Leuk Lymphoma. 1998 Nov;31(5-6):463-76 PMID: 9922037
  52. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.
    J Clin Microbiol. 1999 Apr;37(4):1030-4 PMID: 10074522
  53. Branched DNA signal amplification for direct quantitation of nucleic acid sequences in clinical specimens.
    Adv Clin Chem. 1998;33:201-35 PMID: 10086178
  54. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.
    Cancer Res. 1999 Mar 15;59(6):1188-91 PMID: 10096545
  55. No association between hepatitis C and B-cell lymphoma.
    Hepatology. 1999 Apr;29(4):1259-61 PMID: 10094973
  56. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.
    Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3848-53 PMID: 10097126
  57. Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with a high viral DNA load in leukocytes and presence of CMV DNA in plasma.
    J Infect Dis. 1999 May;179(5):1101-7 PMID: 10191210
  58. Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system.
    J Virol Methods. 1999 Mar;78(1-2):105-16 PMID: 10204701
  59. Prospective longitudinal analysis of quantitative Epstein-Barr virus polymerase chain reaction in pediatric liver transplant recipients.
    Transplantation. 1999 Apr 15;67(7):1068-70 PMID: 10221496
  60. Clinical research is dead; long live clinical research.
    Nat Med. 1999 May;5(5):477-8 PMID: 10229217
  61. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.
    N Engl J Med. 1999 May 27;340(21):1605-13 PMID: 10341272
  62. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.
    N Engl J Med. 1999 May 27;340(21):1614-22 PMID: 10341273
  63. Quantitative analysis of latent human cytomegalovirus.
    J Virol. 1999 Jun;73(6):4806-12 PMID: 10233941
  64. Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus.
    J Virol Methods. 1999 Apr;79(1):33-40 PMID: 10328533
  65. Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.
    J Exp Med. 1999 May 17;189(10):1545-54 PMID: 10330433
  66. Quantification of hepatitis C virus by TaqMan PCR: comparison with HCV Amplicor Monitor assay.
    J Med Virol. 1999 Jun;58(2):121-6 PMID: 10335858
  67. Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays.
    J Virol Methods. 1999 May;79(2):227-35 PMID: 10381092
  68. Monitoring of epstein-barr virus DNA load in peripheral blood by quantitative competitive PCR.
    J Clin Microbiol. 1999 Sep;37(9):2852-7 PMID: 10449464
  69. Dynamics of hepatitis C viremia after plasma exchange.
    J Hepatol. 1999 Sep;31(3):389-93 PMID: 10488694
  70. Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy.
    AIDS. 1998 Dec 24;12(18):2500-2 PMID: 9875591
  71. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.
    Lancet. 1993 Jun 12;341(8859):1501-4 PMID: 8099380
  72. Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS.
    Virology. 1993 Oct;196(2):586-95 PMID: 8103948
  73. Quantification of HPV-16 E6-E7 transcription in cervical intraepithelial neoplasia by reverse transcriptase polymerase chain reaction.
    Int J Cancer. 1993 Sep 30;55(3):397-401 PMID: 7690739
  74. Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C.
    Lancet. 1993 Nov 13;342(8881):1208-9 PMID: 7901531
  75. Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity?
    Hepatology. 1999 Feb;29(2):585-9 PMID: 9918939
  76. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection.
    Int J Cancer. 1999 Jan 18;80(2):237-9 PMID: 9935205
  77. One-tube fluorogenic reverse transcription-polymerase chain reaction for the quantitation of feline coronaviruses.
    J Virol Methods. 1999 Jan;77(1):37-46 PMID: 10029323
  78. Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population.
    Hepatology. 1999 Mar;29(3):904-7 PMID: 10051496
  79. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
    Antivir Ther. 1997 Jul;2(3):175-83 PMID: 11322272
  80. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes.
    Nature. 1986 Nov 13-19;324(6093):163-6 PMID: 3785382
  81. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.
    Science. 1988 Jan 29;239(4839):487-91 PMID: 2448875
  82. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction.
    Proc Natl Acad Sci U S A. 1990 Apr;87(7):2725-9 PMID: 2181447
  83. Genetic disease detection and DNA amplification using cloned thermostable ligase.
    Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):189-93 PMID: 1986365
  84. Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease.
    J Virol. 1992 Jan;66(1):310-6 PMID: 1727491
  85. Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction.
    J Infect Dis. 1992 Jun;165(6):1119-23 PMID: 1583331
  86. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction.
    J Clin Microbiol. 1992 Jul;30(7):1752-7 PMID: 1629331
  87. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients.
    J Infect Dis. 1992 Dec;166(6):1276-80 PMID: 1385547
  88. Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS.
    J Virol. 1992 Dec;66(12):7328-35 PMID: 1433521
  89. Infection of peripheral mononuclear blood cells by hepatitis C virus.
    J Hepatol. 1992 Jul;15(3):382-6 PMID: 1332999
  90. Clearance of HIV-1 viraemia after seroconversion.
    Lancet. 1993 Jan 30;341(8840):315-6 PMID: 8093963
  91. Quantitative PCR and RT-PCR in virology.
    PCR Methods Appl. 1993 Feb;2(3):191-6 PMID: 7680263
  92. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
    Science. 1993 Mar 19;259(5102):1749-54 PMID: 8096089
  93. Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes.
    Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1104-8 PMID: 7905630
  94. Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain.
    J Virol. 1994 Mar;68(3):1864-73 PMID: 8107247
  95. Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo.
    J Virol. 1994 Apr;68(4):2495-502 PMID: 7908061
  96. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia.
    Clin Exp Immunol. 1994 Jul;97(1):87-93 PMID: 8033425
  97. Competitive polymerase chain reaction and analysis of viral activity at the molecular level.
    Genet Anal Tech Appl. 1994;11(1):1-6 PMID: 8060676
  98. Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues.
    Mol Cell Probes. 1994 Jun;8(3):229-34 PMID: 7969197
  99. Quantitation of hepatitis C virus genome molecules in plasma samples.
    J Clin Microbiol. 1994 Aug;32(8):1939-44 PMID: 7527426
  100. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men.
    AIDS. 1994 Sep;8(9):1325-9 PMID: 7802988
  101. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.
    N Engl J Med. 1995 Jan 26;332(4):201-8 PMID: 7808485
Article Info
Journal
Journal of clinical microbiology
Abbr.
J Clin Microbiol
ISSN
0095-1137
DOI
10.1128/JCM.38.6.2030-2036.2000
Email
clementi@popcsi.unian.it
Published
2000-06-00
Pages
2030-6
Language
English
Region
United States
NLM ID
7505564
PMCID
PMC86721
Subset
IM
External Links
PubMed source DOI: 10.1128/JCM.38.6.2030-2036.2000 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2